Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Chromosome 16 open reading frame 52 pseudogene (C16orf52 pseudogene, ENSG00000234607) is a DNA sequence on human chromosome 16 that resembles a functional gene but is classified as a pseudogene, meaning it is incapable of producing a functional protein product[1][2][4]. Pseudogenes are defined by their sequence similarity (homology) to active genes but are unable to function due to disabling mutations such as premature stop codons or frameshifts[2][4]. Most pseudogenes, including this one, arise from gene duplication or retrotransposition and serve no established functional role in healthy tissues. However, some pseudogenes have been reported to regulate gene expression indirectly in rare cases[6]. C16orf52 pseudogene itself is not considered a therapeutic target or biomarker and has no known roles in disease or interaction with drugs. Its presence may complicate genomic studies due to high sequence similarity with functional genes[4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 16 open reading frame 52 pseudogene (C16orf52 pseudogene).